Fig. 2 | Hypertension Research

Fig. 2

From: Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease

Fig. 2

Impact of luseogliflozin treatment on mean arterial pressure (MAP). Average 24-h MAP on a normal-salt diet (NSD, 0.3% NaCl), on a HSD (8% NaCl), and after switching back to a NSD in adenine-induced CKD rats with or without luseogliflozin treatment. *P < 0.05, **P < 0.01, ***P < 0.001 vs. vehicle group; #P < 0.05 vs. adenine group

Back to article page